Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Exits Vaccine-Making Business By Transforming Four Units

This article was originally published in PharmAsia News

Executive Summary

India is no longer in the vaccine business, the country's health minister said. Until now, the government had operated four units to produce vaccines in case of emergencies, but health ministry officials say that backup no longer is necessary. Instead, the facilities are to be used for diagnostic testing, beginning in a few months, with unit employees retrained for their new jobs. The manufacturing licenses of the four units had been suspended in January because they no longer met good manufacturing practices standards. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel